BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24578940)

  • 1. A case of metastatic prostate adenocarcinoma to an inguinal lymph node.
    Komeya M; Sahoda T; Sugiura S; Sawada T; Kitami K
    Cent European J Urol; 2012; 65(2):96-7. PubMed ID: 24578940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted salvage lymphadenectomy in patients treated with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume lymph node recurrence over a long-term follow-up.
    Winter A; Henke RP; Wawroschek F
    BMC Urol; 2015 Feb; 15(1):10. PubMed ID: 25881245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robotic Salvage Lymph Node Dissection After Radical Prostatectomy.
    Torricelli FC; Cividanes A; Guglielmetti GB; Coelho RF
    Int Braz J Urol; 2015; 41(4):819; discussion 820. PubMed ID: 26401879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inguinal Lymphadenopathy After Renal Transplantation Leading to the Diagnosis of Prostate Cancer: A Case Report.
    Enoki Y; Naraki T; Saita K; Mori T; Mitsuke A; Sakaguchi T; Nishimura H; Tatarano S; Yamada Y; Enokida H
    Transplant Proc; 2023 May; 55(4):1092-1094. PubMed ID: 37164802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended lymphadenectomy for high-risk prostate cancer in patients with chronic lymphocytic leukemia may not be necessary: a report of two cases.
    Zhu Y; Wang Y; Qian Z; Pan J; Liu Q; Dong B; Xue W
    BMC Cancer; 2019 Jul; 19(1):676. PubMed ID: 31288785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [COMPLETE RESPONSE OF BULKY LYMPH NODE METASTASES TREATED WITH ENZALUTAMIDE AFTER CHEMOTHERAPY WITH DOCETAXEL IN CASTRATION-RESISTANT PROSTATE CANCER: A CASE REPORT].
    Ishii T; Ide T; Miyajima T; Tominaga K; Miyajima S; Taira H; Haraoka S
    Nihon Hinyokika Gakkai Zasshi; 2019; 110(3):201-205. PubMed ID: 32684582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
    Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
    Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Case of Castration-Resistant Prostate Cancer after Prostatectomy Treated with Resection of A Solitary Metastatic Site].
    Araki H; Igarashi A; Uchida T; Manabe Y; Miyazaki Y; Ito H; Mishina M; Okuno H
    Hinyokika Kiyo; 2020 Dec; 66(12):453-457. PubMed ID: 33435657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nondissection of pelvic lymph nodes does not influence the results of perineal radical prostatectomy in selected patients.
    Salomon L; Hoznek A; Lefrère-Belda MA; Bellot J; Chopin DK; Abbou CC
    Eur Urol; 2000 Mar; 37(3):297-300. PubMed ID: 10720855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of immediate androgen deprivation adjuvant therapy in patients with lymph node positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy].
    Miyamae K; Kitani K; Miyamoto K; Hamada S; Kawano T; Maehara A; Otsuka Y; Otsuka T; Hamada Y
    Nihon Hinyokika Gakkai Zasshi; 2009 Jul; 100(5):570-5. PubMed ID: 19663244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical outcomes of laparoscopic radical prostatectomy for high risk prostate cancer].
    Shao P; Yin C; Li J; Li P; Ju X; Lyu Q; Meng X; Hua L
    Zhonghua Wai Ke Za Zhi; 2015 Nov; 53(11):847-51. PubMed ID: 26813840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinoma arising at a colostomy site with inguinal lymph node metastasis: report of a case.
    Iwamoto M; Kawada K; Hida K; Hasegawa S; Sakai Y
    Jpn J Clin Oncol; 2015 Feb; 45(2):217-20. PubMed ID: 25398580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic adenocarcinoma presenting as isolated inguinal lymphadenopathy.
    Doreswamy K; Karthikeyan VS; Nagabhushana M; Shankaranand B
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26153290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate adenocarcinoma with negative immunohistochemical stain of prostate-specific antigen presenting with cervical mass: A case report.
    Zhu L; Luo C; Wu W; Ying J; Zhong H
    J Res Med Sci; 2013 Sep; 18(9):814-7. PubMed ID: 24381627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should we reconsider the indications for ileo-obturator node dissection with localized prostate cancer?
    Sullivan LD; Rabbani F
    Br J Urol; 1995 Jan; 75(1):33-7. PubMed ID: 7531590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
    Han M; Partin AW; Zahurak M; Piantadosi S; Epstein JI; Walsh PC
    J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.